P

Inventor

SMITH CAMERON

US78 patents
⚠️ This page may combine multiple inventors who share the name “SMITH CAMERON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

THERAVANCE BIOPHARMA R&D IP LLC

20 patents
US10196393B2Feb 5, 2019

JAK inhibitors containing a 4-membered heterocyclic amide

THERAVANCE BIOPHARMA R&D IP LLC24 citations98
US10550118B2Feb 4, 2020

JAK inhibitors containing a 4-membered heterocyclic amide

THERAVANCE BIOPHARMA R&D IP LLC13 citations94
US10526330B2Jan 7, 2020

JAK kinase inhibitor compounds for treatment of respiratory disease

THERAVANCE BIOPHARMA R&D IP LLC15 citations94
US10519153B2Dec 31, 2019

Fused imidazo-piperidine JAK inhibitors

THERAVANCE BIOPHARMA R&D IP LLC16 citations94
US10392386B2Aug 27, 2019

JAK inhibitors containing a 4-membered heterocyclic amide

THERAVANCE BIOPHARMA R&D IP LLC19 citations94
US10208040B2Feb 19, 2019

Fused imidazo-piperidine JAK inhibitors

THERAVANCE BIOPHARMA R&D IP LLC24 citations94
US10100049B2Oct 16, 2018

JAK kinase inhibitor compounds for treatment of respiratory disease

THERAVANCE BIOPHARMA R&D IP LLC28 citations93
US11634419B2Apr 25, 2023

Dimethyl amino azetidine amides as JAK inhibitors

THERAVANCE BIOPHARMA R&D IP LLC6 citations84
US11254669B2Feb 22, 2022

Fused imidazo-piperidine JAK inhibitors

THERAVANCE BIOPHARMA R&D IP LLC3 citations84
US10954237B2Mar 23, 2021

JAK inhibitors containing a 4-membered heterocyclic amide

THERAVANCE BIOPHARMA R&D IP LLC2 citations84
US10947229B2Mar 16, 2021

Dimethyl amino azetidine amides as JAK inhibitors

THERAVANCE BIOPHARMA R&D IP LLC10 citations84
US10836763B2Nov 17, 2020

5 to 7 membered heterocyclic amides as JAK inhibitors

THERAVANCE BIOPHARMA R&D IP LLC12 citations84
US11453668B2Sep 27, 2022

JAK inhibitors containing a 4-membered heterocyclic amide

THERAVANCE BIOPHARMA R&D IP LLC2 citations73
US11299492B2Apr 12, 2022

JAK kinase inhibitor compounds for treatment of respiratory disease

THERAVANCE BIOPHARMA R&D IP LLC2 citations73
US9725448B2Aug 8, 2017

Neprilysin inhibitors

THERAVANCE BIOPHARMA R&D IP LLC1 citations63
US11878977B2Jan 23, 2024

JAK inhibitors containing a 4-membered heterocyclic amide

THERAVANCE BIOPHARMA R&D IP LLC0 citations62
US11718616B2Aug 8, 2023

JAK kinase inhibitor compounds for treatment of respiratory disease

THERAVANCE BIOPHARMA R&D IP LLC0 citations62
US11667637B2Jun 6, 2023

Fused imidazo-piperidine JAK inhibitors

THERAVANCE BIOPHARMA R&D IP LLC0 citations62
US12398135B2Aug 26, 2025

Dimethyl amino azetidine amides as JAK inhibitors

THERAVANCE BIOPHARMA R&D IP LLC0 citations61
US11713315B2Aug 1, 2023

5 to 7 membered heterocyclic amides as JAK inhibitors

THERAVANCE BIOPHARMA R&D IP LLC0 citations61

ADOBE INC

7 patents

SMITH CAMERON

3 patents

SMITH WILLIAM

3 patents

FLEURY MELISSA

2 patents

BLUE COAT SYSTEMS INC

2 patents

HVR MSO LLC

2 patents

GM GLOBAL TECH OPERATIONS LLC

2 patents

GOODMAN JAMES P

2 patents

THERAVANCE INC

1 patent

MERCK SHARP & DOHME

1 patent

CLUB GLIDER HOLDINGS LLC

1 patent

TONG LUCAS

1 patent

ADVANCED BIONICS AG

1 patent

THRIVAL LLC

1 patent

HUSFELD CRAIG

1 patent

Showing the top 50 of 78 patents by PatentIndex Score.